MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the qua...

FDA Device Recall #Z-2867-2017 — Class II — May 22, 2017

Recall Summary

Recall Number Z-2867-2017
Classification Class II — Moderate risk
Date Initiated May 22, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sentinel CH SPA
Location Milan, N/A
Product Type Devices
Quantity 2356 kits Worldwide; US 206 kits

Product Description

MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medical device (chemistry reagent) and is intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems. The kit is provided as a ready to use liquid material consisting in two components: Reagent 1 and Reagent 2. According to the catalogue number, the kit is composed of three vials of 48 ml for Reagent 1 and three vials of 18 ml for Reagent 2 in the configuration 8L24-31. The configuration 8L24-41 consists in ten vials of 90 ml for Reagent 1 and ten vials of 34 ml for Reagent 2

Reason for Recall

Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.

Distribution Pattern

Nationwide Distribution

Lot / Code Information

Catalog Number 8L24-31: Lot Numbers: 60335Y600, 60382Y600 (Exp. Date 2018-02-28); Catalog Number 8L24-41: Lot Number: 60334Y600, (Exp. Date 2018-02-28)

Other Recalls from Sentinel CH SPA

Recall # Classification Product Date
Z-0325-2024 Class II IRON assay, Reference Numbers 6K95-41 and 6K95-30 Sep 29, 2023
Z-0326-2024 Class II Alinity c Iron Reagent, Reference Number 08P3920 Sep 29, 2023
Z-0033-2022 Class III Alinity c CRP Vario Cardiac High Sensitivity Ca... Jul 29, 2021
Z-2012-2021 Class III ACE Control Set - IVD Control set for the quant... Apr 30, 2021
Z-2551-2019 Class II MULTIGENT Lithium-intended for the quantitation... Jun 28, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.